Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-05-24 @ 11:00 AM
Study NCT ID:
NCT00953420
Status:
COMPLETED
Last Update Posted:
2017-08-18
First Post:
2009-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
Sponsor:
Baylor College of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
25145-CADEN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None